Methylation levels depended on the specific location of CpG sites, in detail, the overall promoter methylation level in tumor tissues was significantly higher compared to the overall methylation level in NAT for most of the analyzed CpG sites (Additional file 1: Table S1). This evidence concerns the gene BRD2 and neoplasm.